Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.
Jenko B, Tomšič M, Jekić B, Milić V, Dolžan V, Praprotnik S. Jenko B, et al. Among authors: praprotnik s. Front Pharmacol. 2018 Jan 25;9:20. doi: 10.3389/fphar.2018.00020. eCollection 2018. Front Pharmacol. 2018. PMID: 29422864 Free PMC article.
Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registry.
Rotar Z, Hočevar A, Rebolj Kodre A, Praprotnik S, Tomšič M; Slovenian Rheumatologists. Rotar Z, et al. Among authors: praprotnik s. Clin Rheumatol. 2015 Oct;34(10):1787-93. doi: 10.1007/s10067-015-3066-z. Epub 2015 Sep 7. Clin Rheumatol. 2015. PMID: 26345633
Comment on: High-risk pregnancy and the rheumatologist.
Praprotnik S, Rotar Z, Tomšič M. Praprotnik S, et al. Rheumatology (Oxford). 2015 Dec;54(12):2292. doi: 10.1093/rheumatology/kev369. Epub 2015 Oct 10. Rheumatology (Oxford). 2015. PMID: 26454693 No abstract available.
The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs-BioRx.si.
Rotar Ž, Tomšič M, Praprotnik S; Slovenian Rheumatologists. Rotar Ž, et al. Among authors: praprotnik s. Clin Rheumatol. 2019 Feb;38(2):297-305. doi: 10.1007/s10067-018-4324-7. Epub 2018 Oct 15. Clin Rheumatol. 2019. PMID: 30324406
95 results